Clinical trial
Combination Chemotherapy Following Surgery in Treating Patients With Urinary…
NCT00028860 · Tulane University Health Sciences Center, Other · Completed
Key facts
| NCT number | NCT00028860 |
|---|---|
| Title | Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer |
| Official title | A Phase II Trial Of Adjuvant Chemotherapy For High Risk Transitional Cell Carcinoma Of The Urothelium |
| Lead sponsor | Tulane University Health Sciences Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, carboplatin, gemcitabine hydrochloride, ifosfamide, paclitaxel, adjuvant therapy |
| Start date | Oct 1, 2001 |
| Completion | Oct 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: